FMP

FMP

Enter

SBFM - Sunshine Biopharma, ...

Financial Summary of Sunshine Biopharma, Inc.(SBFM), Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the resear

photo-url-https://financialmodelingprep.com/image-stock/SBFM.png

Sunshine Biopharma, Inc.

SBFM

NASDAQ

Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.

1.21 USD

-0.23 (-19.01%)

About

ceo

Dr. Steve N. Slilaty Ph.D.

sector

Healthcare

industry

Drug Manufacturers - Specialty & Generic

website

https://www.sunshinebiopharma.com

exchange

NASDAQ

Description

Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand ...

CIK

0001402328

ISIN

US8677814035

CUSIP

867781304

Address

6500 Trans-Canada Highway

Phone

514 426 6161

Country

CA

Employee

44

IPO Date

Feb 15, 2022

Summary

CIK

0001402328

Exchange

NASDAQ

Industry

Drug Manufacturers -...

Sector

Healthcare

CUSIP

867781304

ISIN

US8677814035

Country

CA

Price

1.21

Beta

-1.1

Volume Avg.

641.84k

Market Cap

1.2M

Shares

-

52-Week

1.15-140.0

DCF

1.08

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.06

P/B

-

Website

https://www.sunshinebiopharma.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest SBFM News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep